RxDoctor Payments Data

Dana Wyatt

Nurse Practitioner · Cynthiana, KYNPI 1407215692

Payments from drug & device makers

$2,041in general payments, 2019–2025

Across 133 payments — averaging $15.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$280
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$212
  • Novo Nordisk$209
  • Johnson & Johnson$182
  • Bayer$156
  • AstraZeneca$142
  • plus $859 from 18 others

What the payments were for

  • Food & beverage$2,041100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,041 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$37,256
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$27,977
JardianceEmpagliflozin32$27,695
FarxigaDapagliflozin Propanediol29$26,784
XareltoRivaroxaban28$20,002
EliquisApixaban16$15,381
RybelsusSemaglutide13$12,387
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$9,044
Breo ElliptaFluticasone/Vilanterol15$8,930
JanumetSitagliptin Phos/Metformin Hcl15$8,569
TradjentaLinagliptin15$7,086
InvokanaCanagliflozin13$6,882
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,886
Albuterol Sulfate HfaAlbuterol Sulfate91$2,889
Aripiprazole20$2,289

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$209$49,64341 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$38$42,79453 claims
AstraZenecaFarxiga, Breztri Aerosphere$142$35,82842 claims
Johnson & JohnsonXarelto, Invokana$182$26,88341 claims
PfizerEliquis$58$15,38116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Cynthiana

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →